Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James A. Schoeneck currently holds 7,000 shares of Calidi Biotherapeutics, Inc. (CLDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James A. Schoeneck has been a net seller of CLDI stock. They have purchased $499.8K and sold $2.4M worth of shares.
James A. Schoeneck's most recent insider trade was on Jun 12, 2026, when they sold 7,000 shares at $0.00 per share.
James A. Schoeneck serves as Executive at Calidi Biotherapeutics, Inc. (CLDI). They have executed 102 insider transactions totaling $2.9M over their tenure at the company.
James A. Schoeneck holds the position of Executive at Calidi Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
James A. Schoeneck has shown a selling trading pattern, with $499.8K in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James A. Schoeneck was on Jul 3, 2018, when they sold $496.5K worth of FGEN shares. This transaction involved 7,639 shares at $65.00 per share.
James A. Schoeneck currently owns 7,000 shares of Calidi Biotherapeutics, Inc. (CLDI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James A. Schoeneck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James A. Schoeneck has 102 Form 4 filings on record as an insider at Calidi Biotherapeutics, Inc..
Set alerts for James A. Schoeneck and 40,000+ other insiders.